Internal Medicine, Hematology & Oncology · Riverside, CA
NPI
1205028404
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
10800 Magnolia Ave # 438
Riverside, CA, 92505
Phone (951) 353-4418
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
1,332 services
Medicare patients, 2024
23
Average age 70
Drug cost, 2024
$3.5M
1,563 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Annie L Oh prescribed most often to Medicare patients was Anastrozole, with 186 prescriptions and refills. In total Annie L Oh wrote 1,563 Medicare prescriptions that cost $3.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 186 | 562 | 62 | $5,244 |
| Hydroxyurea Generic | 85 | 262 | 31 | $3,646 |
| Abiraterone Acetate Generic | 84 | 88 | 15 | $12K |
| Prednisone Generic | 73 | 106 | 20 | $561 |
| Dexamethasone Generic | 71 | 87 | 18 | $865 |
| Ondansetron Hcl Generic | 67 | 67 | 31 | $537 |
| Letrozole Generic | 62 | 148 | 20 | $1,054 |
| Lenalidomide Generic | 59 | 59 | Under 11 | $673K |
| Xtandi Enzalutamide | 45 | 45 | Under 11 | $523K |
| Pradaxa Dabigatran Etexilate Mesylate | 44 | 112 | 14 | $11K |
| Calquence Acalabrutinib Maleate | 43 | 43 | Under 11 | $591K |
| Raloxifene Hcl Generic | 43 | 126 | 12 | $1,770 |
| Imatinib Mesylate Generic | 35 | 47 | Under 11 | $1,702 |
| Potassium Chloride Generic | 33 | 43 | 18 | $452 |
| Tamoxifen Citrate Generic | 32 | 105 | 12 | $875 |
Brand drugs: 348 claims; generic drugs: 1,215 claims; opioid claims: 24.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Annie L Oh were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.